Does Beta-Blockade Reduce the Risk of Depression in Patients with Isolated Severe Extracranial Injuries?

Area of Science:

• Trauma care
• Psychiatry
• Pharmacology

Background:

• Post-traumatic depression affects approximately 50% of trauma survivors.
• Beta-blockade may reduce depressive symptoms by impairing trauma memory recall.
• This study focuses on early beta-blockade's impact on depression in severe trauma patients without brain injury.

Purpose of the Study:

• To investigate the effect of early beta-blockade on the incidence of post-traumatic depression.
• To determine if pre-admission beta-blocker use influences depression risk after severe trauma.

Main Methods:

• Retrospective review of trauma registry data (2007-2011) from an urban university hospital.
• Inclusion criteria: severe extracranial injuries (AIS score ≥3), mild intracranial injury (AIS score <3), Injury Severity Score ≥16.
• Exclusion criteria: in-hospital deaths, prior antidepressant use; stratification by pre-admission beta-blocker status.

Main Results:

• 596 patients met criteria; 11.4% used pre-admission beta-blockers.
• Beta-blocker group was older, had lower Glasgow Coma Scale scores, and longer hospital/ICU stays.
• Lack of beta-blockade was associated with increased depression risk (AOR 3.3, 95% CI 1.2-8.6, p=0.02) after adjustment.

Conclusions:

• Pre-admission beta-blockade is associated with a significantly reduced risk of depression post-severe traumatic injury.
• Further research is warranted to confirm the beneficial role of beta-blockade in trauma patients.
• Findings suggest beta-blockers as a potential preventative strategy for post-traumatic depression.